top of page
본 사이트는
.com
사이트 제작 도구로 제작되었습니다. 지금 나만의 사이트를 만들어보세요.시작하기
Lab member's publication list

    

2020.

Oh S, Jo Y, Jung S, Yoon S, and Yoo KH., From Genome Sequencing to the Discovery of Potential Biomarkers in Liver Disease., BMB Rep. 2020 May, Article in press 

​

2019.

Kim BH, Kim DY, Oh S, Ko JY, Rah G, Yoo KH, Park JH., Deficiency of calpain-6 inhibits primary ciliogenesis., BMB Rep. 2019 Oct, PMID: 31619317

Park JY, Han S, Ka HI, Joo HJ, Soh SJ, Yoo KH, Yang Y., Silent mating-type information regulation 2 homolog 1 overexpression is an important strategy for the survival of adapted suspension tumor cells., Cancer Sci. 2019 Sep, PMID: 31348594

Shin HY, Hennighausen L, Yoo KH.​, STAT5-Driven Enhancers Tightly Control Temporal Expression of Mammary-Specific Genes., J Mammary Gland Biol Neoplasia. 2019 Mar, PMID: 30328555

Yoo KH, Hennighausen L, Shin HY., Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing., J Mammary Gland Biol Neoplasia. 2019 Mar, PMID: 30291498

Kim DY, Woo YM, Lee S, Oh S, Shin Y, Shin JO, Park EY, Ko JY, Lee EJ, Bok J, Yoo KH, Park JH., Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease., FASEB J. 2019 Feb, PMID: 30332302

​

2018.

Bae WK, Kwon J, Lee HW, Lee SC, Song EK, Shim H, Ryu KH, Song J, Seo S, Yang Y, Park JH, Lee KH, Han HS., Feasibility and accessibility of electronic patient-reported outcome measures using a smartphone during routine chemotherapy: a pilot study., Support Care Cancer. 2018 Nov, PMID: 29732483

Han S, Jeong AL, Lee S, Park JS, Buyanravjikh S, Kang W, Choi S, Park C, Han J, Son WC, Yoo KH, Cheong JH, Oh GT, Lee WY, Kim J, Suh SH, Lee SH, Lim JS, Lee MS, Yang Y., C1q/TNF-α-Related Protein 1 (CTRP1) Maintains Blood Pressure Under Dehydration Conditions., Circ Res. 2018 Aug 17, PMID: 30030219

Bae WK, Hong CS, Park MR, Sun EG, Lee JH, Kang K, Ryu KH, Shim HJ, Hwang JE, Cho SH, Chung IJ., TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma., Cancer Lett. 2018 Feb, PMID: 29222041

​

2017.

Oh S, Ko JY, Oh C, Yoo KH., Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer., Adv Exp Med Biol, PMID: 29282690 

Oh S, Oh C, Yoo KH., Functional roles of CTCF in breast cancer., BMB Rep. 2017 Jun 26, PMID: 28648147

Ko JY, Oh S, Yoo KH., Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development., Mol Cells. 2017 Mar, PMID: 28359147

​

​

Professor's publication list

  1. Shin HY, Willi M, Yoo KH (*co-first author), Zeng X, Wang C, Metser G, Hennighausen L, Hierarchy within a mammary-specific and hormone-sensing super-enhancer. Nature Genetics, 2016, in Revision

  2. Shin HY, Wang C, Lee HK, Yoo KH, Zeng X, Kuhns T, Yang CM, Mohr T, Liu C, Hennighausen L., CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome., Nat Commun. 2017 May 31, PMID: 28561021

  3. Yu S, Kim T, Yoo KH, Kang K., The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer., Biochem Biophys Res Commun. 2017 May 6, PMID: 28342866

  4. Willi M, Yoo KH, Wang C, Trajanoski Z, Hennighausen L., Differential cytokine sensitivities of STAT5-dependent enhancers rely on Stat5 autoregulation., Nucleic Acids Res. 2016, PMID: 27694626

  5. Yoo KH (*First author), Oh S, Kang K, Wang C, Robinson GW, Ge K, Hennighausen L, The histone demethylase KDM6A controls the mammary luminal lineage through enzyme- independent mechanisms. Mol Cell Biol. 2016 May 23, PMID: 27215382.

  6. Sakamoto K, Wehde BL, Yoo KH, Kim T, Rajbhandari N, Shin HY, Triplett AA, Rädler PD, Schuler F, Villunger A, Kang K, Hennighausen L, Wagner KU. Janus kinase 1 is essential for inflammatory cytokine signaling and mammary gland remodeling. Mol Cell Biol. 2016, 36(11): 1673-90.

  7. Metser G, Shin HY, Wang C, Yoo KH, Oh S, Villarino AV, O'Shea JJ, Kang K, Hennighausen L. An autoregulatory enhancer controls mammary-specific STAT5 functions. Nucleic Acids Res. 2016, 44(3):1052-63.

  8. Yoo KH (*First author), Oh S, Kang K, Hensel T, Robinson GW, Hennighausen L. Loss of EZH2 results in precocious mammary gland development and activation of STAT5-dependent genes. Nucleic Acids Res. 2015, 43(18):8774-89.

  9. Bae WK, Kang K, Yu JH, Yoo KH (*co-first author), Factor VM, Kaji K, Matter M, Thorgeirsson S, Hennighausen L. The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration. FASEB J, 2015, 29(5):1653-62.

  10. Yoo KH (*First author), Kang K, Feuermann Y, Jang SJ, Robinson GW, Hennighausen L. The STAT5-regulated miR-193b locus restrains mammary stem and progenitor cell activity and alveolar differentiation. Developmental Biology, 2014, 395(2):245-54.

  11. Bae WK, Yoo KH, Lee JS, Kim Y, Chung IJ, Park MH, Yoon JH, Furth PA, Hennighausen L. The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers. Mol Carcinog. 2015, 54(10):1172-80.

  12. Lee EJ, Song SA, Mun HW, Yoo KH, Choi SY, Park EY, Park JH. Blockade of interleukin-8 receptor signalling inhibits cyst development in vitro, via suppression of cell proliferation in autosomal polycystic kidney disease. Nephrology (Carlton), 2014, 19(8):471-8.

  13. Robinson GW, Kang K, Yoo KH (*co-first author), Tang Y, Zhu BM, Yamaji D, Colditz V, Jang SJ, Gronostajski RM, Hennighausen L. Coregulation of genetic programs by the transcription factors NFIB and STAT5. Mol Endocrinol, 2014, 28(5):758-67.

  14. Feuermann Y, Kang K, Gavrilova O, Haetscher N, Jang SJ, Yoo KH, Jiang C, Gonzalez FJ, Robinson GW, Hennighausen L. MiR-193b and miR-365-1 are not required for the development and function of brown fat in the mouse. RNA Biol. 2013, 1;10(12):1807-14.

  15. Kang K, Yamaji D, Yoo KH, Robinson GW, Hennighausen L. Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. Mol Cell Biol, 2014, 34(3):464-73.

  16. Ko JY, Yoo KH (*co-first author), Song SA, Kim do Y, Kong HK, Ahn C, Lee HW, Kang DH, Oh GT, Park JH. Inactivation of max-interacting protein 1 induces renal cilia disassembly through reduction in levels of intraflagellar transport 20 in polycystic kidney. J Biol Chem., 2013, 1;288(9):6488-97.

  17. Kim BH, Park EY, Yoo KH, Choi KM, Kim Y, Seong Jk, Park JH. N-myc downstream-regulated gene 1 is involved in the regulation of cystogenesis in transgenic mice overexpressing human PKD2 gene. Proteomics. 2013, 13(1):134-41.

  18. Yook YJ, Yoo KH, Song SA, Seo MJ, Ko JY, Kim BH, Lee EJ, Chang E, Woo YM, Park JH. Mxi1 influences cyst formation in three-dimensional cell culture. BMB Rep., 2012, 45(3):189-93.

  19. Song SA, Yoo KH, Ko JY, Kim BH, Yook YJ, Park JH. Over-expression of Mxi1 represses renal epithelial tubulogenesis through the reduction of matrix metalloproteinase 9, Biochem. Biophys. Res. Commun., 2012, 419(3):459-65.

  20. Ko JY, Yoo KH, Lee HW, Park JH, Mxi1 regulates cell proliferation through insulin-like growth factor binding protein-3, Biochem. Biophys. Res. Commun., 2011, 415(1):36-41.

  21. Yoo KH (*First author), Hennighausen L, EZH2 methyltransferase and H3K27 methylation in Breast Cancer. Int. J. Biol. Sci. 2011, 8(1):59-65.

  22. Yoo KH (*First author), Baik M, Hennighausen L, Context-Specific Growth Hormone Signaling through the Transcription Factor STAT5: Implications for the Etiology of Hepatosteatosis and Hepatocellular Carcinoma. Genes and Cancer, 2011, 2(1):3-9.

  23. Shim JH, Cho SA, Seo MJ, Kim JH, Ryu NK, Yoo KH, Yang MH, Kim S, Bahk YY, Park JH. Proteomic analysis of time-dependent difference of protein expression profile changes during neuronal differentiation of mouse embryonic stem cells. Mol Cells, 2010, 29(3):239-44.

  24. Yoo KH (*First author), Kim YN, Lee MJ, Seong JK, Park JH, Identification of apolipoproteinA1 reduction in the polycystic kidney by proteomics analysis of the Mxi1-deficient mouse, Proteomics, 2009, 9(15):3824-3832.

  25. Park EY, Sung YH, Yang MH, Noh JY, Park SY, Lee TY, Yook YJ, Yoo KH, Roh KJ, Kim I, Hwang YH, Oh GT, Seong JK, Ahn C, Lee HW, Park JH. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice. J. Biol. Chem., 2009, 284(11):7214-22.

  26. Yoo KH (*First author), Lee TY, Yang MH, Park EY, Yook YJ, Lee HS, Park JH. NCAM as a cystogenesis marker gene of PKD2 overexpression. BMB Rep, 2008, 41(8):593-6.

  27. Suh YJ, Cho SA, Shim JH, Yook YJ, Yoo KH, Kim JH, Park EY, Noh JY, Lee SH, Yang MH, Jeong HS, Park JH. Gene discovery analysis from mouse embryonic stem cells based on time course microarray data. Mol. Cells, 2008, 26(4):338-43.

  28. Yang MH, Jung MS, Lee MJ, Yoo KH, Yook YJ, Park EY, Choi SH, Suh YJ, Kim KW, Park JH. Gene expression profiling of the rewarding effect caused by methamphetamine in the mesolimbic dopamine system. Mol. Cells, 2008, 26(2):121-30.

  29. Kim JH, Lee TY, Yoo KH, Lee HS, Cho SA, Park JH. Expression profile identifies novel genes involved in neuronal differentiation. BMB Rep., 2008, 41(2):146-52.

  30. Park MH, Cho SA, Yoo KH, Yang MH, Ahn JY, Lee HS, Lee KE, Mun YC, Cho DH, Seong CM, Park JH. Gene expression profile related to prognosis of acute myeloid leukemia. Oncol. Rep., 2007, 18(6):1395-402.

  31. Jeon JO, Yoo KH, Park JH. Expression of the Pkd1 gene is momentously regulated by Sp1. Nephron Exp. Nephrol., 2007, 107(2):e57-64.

  32. Yang MH, Yoo KH, Yook YJ, Park EY, Jeon JO, Choi SH, Park SY, Woo YM, Lee MJ, Park JH. The gene expression profiling in murine cortical cells undergoing programmed cell death (PCD) induced by serum deprivation. J. Biochem. Mol. Biol., 2007, 40(2):277-85.

  33. Yoo KH (*First author), Sung YH, Yang MH, Jeon JO, Yook YJ, Woo YM, Lee HW, Park JH. Inactivation of Mxi1 induces Il-8 secretion activation in polycystic kidney. Biochem. Biophys. Res. Commun., 2007, 356(1):85-90.

  34. Lee JW, Lee YS, Yoo KH, Lee KH, Park K, Ahn T, Ko C, Park JH. LY-6K gene: a novel molecular marker for human breast cancer. Oncol. Rep., 2006, 16(6):1211-4. 

bottom of page